Patent · US Active

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride

US9108961B2 · kind B2 · utility

3Cited by

56References

16Claims

0Family size

Assignee

Forum Pharmaceuticals, Inc. · US

Inventors

Patricia Oliver-Shaffer · Acton, US
Gideon Shapiro · Gainesville, US
Richard Chesworth · Boston, US
Muneki Kishida · Osaka, JP
Takayuki Ishige · Osaka, JP

Key dates

Filing date	Feb 19, 2014
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Feb 19, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.